Form 4/A for BLFS BIOLIFE SOLUTIONS INC
Accepted 2022-02-17 00:00:00 ET · period of report 2022-01-07 · accession 0001437749-22-003761 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2022-02-17 | 2022-01-07 | BLFS | Wichterman Troy | CFO | S - Sale | $30.75 | -47 | 22.1K | -0.2% | -$1,445 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-07 | S | D | 47 | $30.75 | 22,075 | D | — | — | (F2) On January 11, 2022, the reporting person filed a Form 4 which inadvertently reported in Column 4 of Table I that the sale to cover transaction was an acquisition of securities rather than a disposition of securities. In fact, as reported in this amendment, the reporting person disposed of those shares. |